NCT06925685

Follow-Up for Study Participants Treated With an Allogeneic CAR T-Cell Product

Long Term Follow up Study for Participants Treated With an Allogeneic CAR T-Cell Product in a Prior Clinical Study

• Status: Enrolling By Invitation
• Phase: —
• Study type: Observational
• Enrollment: 50 (estimated)
• Sponsor: Allogene Therapeutics · Industry
• Sex: All
• Age: —
• Healthy volunteers: Not accepted

Summary

An observational, long-term follow up (LTFU) study of participants who received an allogeneic CAR T product in a prior clinical study. Participants will be followed for 15 years after their last infusion of an allogenic CAR T cell product.

Conditions

• Hematologic Malignancies
• Solid Tumors

Timeline

• Start date: 2025-01-31
• Primary completion: 2039-01-01
• Completion: 2039-01-01
• First posted: 2025-04-13
• Last updated: 2025-04-13

Locations

1 site across 1 country: United States